Reconciling markedly discordant values of serum ferritin versus reticulocyte hemoglobin content.


Journal

Journal of perinatology : official journal of the California Perinatal Association
ISSN: 1476-5543
Titre abrégé: J Perinatol
Pays: United States
ID NLM: 8501884

Informations de publication

Date de publication:
03 2021
Historique:
received: 20 04 2020
accepted: 24 09 2020
revised: 02 09 2020
pubmed: 6 10 2020
medline: 1 9 2021
entrez: 5 10 2020
Statut: ppublish

Résumé

To determine why serum ferritin and reticulocyte hemoglobin (RET-He), drawn to assess neonatal iron sufficiency, sometimes have markedly discordant results. Retrospective records review of five NICUs over 28 months, identifying all patients with a ferritin and RET-He within 48 h. We examined records of all who had marked discordance (one value >95th % reference interval, the other <5th %). Of 190 paired ferritin and RET-He measurements, 16 (8%) were markedly discordant. Fifteen of the 16 discordant samples involved a high ferritin and a low RET-He. In these, low MCV and high %Micro-R, and low MCH and high %HYPO-He were present. In total, 8 of the 15 had laboratory or clinical evidence of an inflammatory process and five had suspicion of infection documented. When ferritin and RET-He were discordant, erythrocyte microcytosis and hypochromasia suggested that the RET-He gave the more accurate interpretation; that iron deficiency was likely present.

Identifiants

pubmed: 33012780
doi: 10.1038/s41372-020-00845-2
pii: 10.1038/s41372-020-00845-2
doi:

Substances chimiques

Hemoglobins 0
Ferritins 9007-73-2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

619-626

Subventions

Organisme : NIDDK NIH HHS
ID : U54 DK110858
Pays : United States

Références

Kling PJ. Iron nutrition, erythrocytes, and erythropoietin in the NICU: erythropoietic and neuroprotective effects. Neoreviews. 2020;21:e80–8.
doi: 10.1542/neo.21-2-e80
Cusick SE, Georgieff MK, Rao R. Approaches for reducing the risk of early-life iron deficiency-induced brain dysfunction in children. Nutrients. 2018;10:227.
doi: 10.3390/nu10020227
Geng F, Mai X, Zhan J, Xu L, Zhao Z, Georgieff M, et al. Impact of fetal-neonatal iron deficiency on recognition memory at 2 months of age. J Pediatr. 2015;167:1226–32.
doi: 10.1016/j.jpeds.2015.08.035
Armony-Sivan R, Eidelman AI, Lanir A, Sredni D, Yehuda S. Iron status and neurobehavioral development of premature infants. J Perinatol. 2004;24:757–62.
doi: 10.1038/sj.jp.7211178
Amin SB, Orlando M, Eddins A, MacDonald M, Monczynski C, Wang H. In utero iron status and auditory neural maturation in premature infants as evaluated by auditory brainstem response. J Pediatr. 2010;156:377–81.
doi: 10.1016/j.jpeds.2009.09.049
McArdle HJ, Danzeisen R, Fosset C, Gambling L. The role of the placenta in iron transfer from mother to fetus and the relationship between iron status and fetal outcome. Biometals. 2003;16:161–7.
doi: 10.1023/A:1020714915767
Riggins T, Miller NC, Bauer PJ, Georgieff MK, Nelson CA. Consequences of low neonatal iron status due to maternal diabetes mellitus on explicit memory performance in childhood. Dev Neuropsychol. 2009;34:762–79.
doi: 10.1080/87565640903265145
Kim HA, Park SH, Lee EJ. Iron status in small for gestational age and appropriate for gestational age infants at birth. Korean J Pediatr. 2019;62:102–7.
doi: 10.3345/kjp.2018.06653
Georgieff MK. Iron assessment to protect the developing brain. Am J Clin Nutr. 2017;106:1588S–93S.
doi: 10.3945/ajcn.117.155846
Garcia-Casal MN, Pasricha SR, Martinez RX, Lopez-Perez L, Peña-Rosas JP. Are current serum and plasma ferritin cut-offs for iron deficiency and overload accurate and reflecting iron status? A Systematic Review. Arch Med Res. 2018;49:405–17.
doi: 10.1016/j.arcmed.2018.12.005
MacQueen BC, Christensen RD, Ward DM, Bennett ST, O’Brien EA, Sheffield MJ, et al. The iron status at birth of neonates with risk factors for developing iron deficiency: a pilot study. J Perinatol. 2017;37:436–40.
doi: 10.1038/jp.2016.234
Alm S, Sjostrom ES, Sommar JN, Domellof M. Erythrocyte transfusions increased the risk of elevated serum ferritin in very low birth weight infants and were associated with altered longitudinal growth. Acta Paediatr. 2019. https://doi.org/10.1111/apa15115
Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol. 2006;28:303–8.
doi: 10.1111/j.1365-2257.2006.00812.x
Lorenz L, Arand J, Büchner K, Wacker-Gussmann A, Peter A, Poets CF, et al. Reticulocyte haemoglobin content as a marker of iron deficiency. Arch Dis Child Fetal Neonatal Ed. 2015;100:F198–202.
doi: 10.1136/archdischild-2014-306076
Piva E, Brugnara C, Spolaore F, Plebani M. Clinical utility of reticulocyte parameters. Clin Lab Med. 2015;35:133–63.
doi: 10.1016/j.cll.2014.10.004
Christensen RD, Henry E, Bennett ST, Yaish HM. Reference intervals for reticulocyte parameters of infants during their first 90 days after birth. J Perinatol. 2016;36:61–6.
doi: 10.1038/jp.2015.140
Al-Ghananim RT, Nalbant D, Schmidt RL, Cress GA, Zimmerman MB, Widness JA. Reticulocyte hemoglobin content during the first month of life in critically ill very low birth weight neonates differs from term infants, children, and adults. J Clin Lab Anal. 2016;30:326–34.
doi: 10.1002/jcla.21859
Lorenz L, Peter A, Arand J, Springer F, Poets CF, Franz AR. Reticulocyte haemoglobin content declines more markedly in preterm than in term infants in the first days after birth. Neonatology. 2017;112:246–50.
doi: 10.1159/000477124
Lorenz L, Peter A, Arand J, Springer F, Poets CF, Franz AR. Reference ranges of reticulocyte haemoglobin content in preterm and term infants: A retrospective analysis. Neonatology. 2017;111:189–94.
doi: 10.1159/000450674
Buttarello M, Rauli A, Mezzapelle G. Reticulocyte count and extended reticulocyte parameters by Mindray BC-6800: Reference intervals and comparison with Sysmex XE-5000. Int J Lab Hematol. 2017;39:596–603.
doi: 10.1111/ijlh.12705
Löfving A, Domellöf M, Hellström-Westas L, Andersson O. Reference intervals for reticulocyte hemoglobin content in healthy infants. Pediatr Res. 2018;84:657–61.
doi: 10.1038/s41390-018-0046-4
Ennis KM, Dahl LV, Rao RB, Georgieff MK. Reticulocyte hemoglobin content as a nearly predictive biomarker of brain iron-deficiency. Pediatr Res. 2018;84:765–9.
doi: 10.1038/s41390-018-0178-6
Amin K, Bansal M, Varley N, Wang H, Amin S. Reticulocyte hemoglobin content as a function of iron stores at 35-36 weeks post menstrual age in very premature infants. J Matern Fetal Neonatal Med. 2019;1–6. [published online ahead of print].
German K, Vu PT, Irvine JD, Juul SE. Trends in reticulocyte hemoglobin equivalent values in critically ill neonates, stratified by gestational age. J Perinatol. 2019;39:1268–74.
doi: 10.1038/s41372-019-0434-6
Urrechaga E, Borque L, Escanero JF. Potential utility of the new Sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism. Clin Chem Lab Med. 2009;47:1411–6.
doi: 10.1515/CCLM.2009.301
Buttarello M, Pajola R, Novello E, Mezzapelle G, Plebani M. Evaluation of the hypochromic erythrocyte and reticulocyte hemoglobin content provided by the Sysmex XE-5000 analyzer in diagnosis of iron deficiency erythropoiesis. Clin Chem Lab Med. 2016;54:1939–45.
doi: 10.1515/cclm-2016-0041
Levy S, Schapkaitz E. The clinical utility of new reticulocyte and erythrocyte parameters on the Sysmex XN 9000 for iron deficiency in pregnant patients. Int J Lab Hematol. 2018;40:683–90.
doi: 10.1111/ijlh.12904
Schapkaitz E. Stability of new erythrocyte and reticulocyte parameters in testing for anemia on the Sysmex XN 9000. Lab Med. 2018;49:219–25.
pubmed: 29365192
Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics. 1998;102:E41.
doi: 10.1542/peds.102.4.e41
MacQueen BC, Christensen RD, Yoder BA, Henry E, Baer VL, Bennett ST, et al. Comparing automated vs manual leukocyte differential counts for quantifying the ‘left shift’ in the blood of neonates. J Perinatol. 2016;36:843–8.
doi: 10.1038/jp.2016.92
Henry E, Christensen RD, Sheffield MJ, Eggert LD, Carroll PD, Minton SD, et al. Why do four NICUs using identical RBC transfusion guidelines have different gestational age-adjusted RBC transfusion rates? J Perinatol. 2015;35:132–6.
doi: 10.1038/jp.2014.171
Maxwell JR, Ohls RK. Update on erythropoiesis-stimulating agents administered to neonates for neuroprotection. Neoreviews. 2019;20:e622–35.
doi: 10.1542/neo.20-11-e622
Weiss G, Goodnough LT. Anemia of chronic disease. N Eng J Med. 2005;352:1011–23.
doi: 10.1056/NEJMra041809
Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: past, present and future. Biochim Biophys Acta. 2010;1800:760–9.
doi: 10.1016/j.bbagen.2010.03.011
MacQueen BC, Christensen RD, Baer VL, Ward DM, Snow GL. Screening umbilical cord blood for congenital Iron deficiency. Blood Cells Mol Dis. 2019;77:95–100.
doi: 10.1016/j.bcmd.2019.04.005
DeLoughery TG. Iron deficiency anemia. Med Clin North Am. 2017;101:319–32.
doi: 10.1016/j.mcna.2016.09.004
Christensen RD, Jopling J, Henry E, Wiedmeier SE. The erythrocyte indices of neonates, defined using data from over 12,000 patients in a multihospital health care system. J Perinatol. 2008;28:24–8.
doi: 10.1038/sj.jp.7211852
Siddappa AM, Olson RM, Spector M, Northrop E, Zamora T, Brearley AM, et al. High prevalence of iron deficiency despite standardized high-dose iron supplementation during recombinant erythropoietin therapy in extremely low gestational age newborns [published online ahead of print, 2020 May 14]. J Pediatr. 2020;S0022-3476:30434–0.
Spencer BR, Brodsky JP, Holley GC, Foster GA, Winton C, Stramer SL. Expanded feasibility of ferritin testing: stability of ferritin stored as whole blood and validation of plastic tubes. Transfusion. 2019;59:3424–30.
doi: 10.1111/trf.15513

Auteurs

Timothy M Bahr (TM)

Division of Neonatology, University of Utah Health, Salt Lake City, UT, USA. tim.bahr@hsc.utah.edu.

Vickie L Baer (VL)

Women and Newborns Research, Intermountain Healthcare, Murray, UT, USA.

Robin K Ohls (RK)

Division of Neonatology, University of Utah Health, Salt Lake City, UT, USA.

Thomas R Christensen (TR)

University of Utah student, Salt Lake City, UT, USA.

Diane M Ward (DM)

Department of Pathology, University of Utah, Salt Lake City, UT, USA.

Sterling T Bennett (ST)

Department of Pathology, Intermountain Medical Center, Murray, UT, USA.

Robert D Christensen (RD)

Division of Neonatology, University of Utah Health, Salt Lake City, UT, USA.
Women and Newborns Research, Intermountain Healthcare, Murray, UT, USA.
Division Hematology/Oncology, Department of Pediatrics, University of Utah Health, Salt Lake City, UT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH